Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00424710
Recruitment Status : Completed
First Posted : January 19, 2007
Last Update Posted : November 5, 2014
Genentech, Inc.
Information provided by (Responsible Party):
Gregg T. Kokame, MD, Hawaii Pacific Health

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2010
  Study Completion Date : September 2010